Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

January 15, 2026 updated by: ICU, National Hepatology & Tropical Medicine Research Institute

Balancing Time and Outcomes: A Prospective Observational Study Comparing the Effectiveness of the Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

this study aims to compare the effectiveness of a one-day versus two-day ALS recertification course in terms of knowledge retention, practical skills performance, participant satisfaction, and confidence.

Study Overview

Status

Recruiting

Conditions

Detailed Description

demographic data will be collected, including participants' age, sex, specialty, prior ALS course completion, participation in resuscitation teams, last CPR performance, and total online learning hours (minimum 16 hours for the standard ALS course and 8 hours for the recertification course). All ALS courses (standard and recertification) will be conducted in accordance with the standardized curriculum, structure, and educational formats established by the European Resuscitation Council (ERC).

Assessments:

A. Knowledge Assessment B. Practical Skills Performance C. Participant satisfaction and confidence at the end of each course

• Scoring: 0 = Not performed/incorrect, 1 = Partially/performed with prompting, 2 = Performed correctly and independently.

Study Type

Observational

Enrollment (Estimated)

158

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Eman Ibrahim El-Desoki Mahmoud, MD, intensive care medicine
  • Phone Number: +2 01227409501
  • Email: eman18350@gmail.com

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

demographic data will be collected, including participants' age, sex, specialty, prior ALS course completion, participation in resuscitation teams, last CPR performance, and total online learning hours (minimum 16 hours for the standard ALS course and 8 hours for the recertification course).

Description

Inclusion Criteria:

  • Adult healthcare professionals (≥18 years) requiring ALS recertification, including doctors, nurses, and paramedics, who can attend the assigned course and follow-up assessments.

Exclusion Criteria:

  • Participants will be excluded if they cannot attend the assigned course or decline consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
standard ALS course
Two day course
Recertification Course
one day course

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
overall effectiveness between the two-day stanrdand one-day ALS recertification
Time Frame: 24hours precourse
• Baseline knowledge score
24hours precourse
Practical skill effectiveness
Time Frame: 48 and 24 hours from standard amd recertification course respectively
• Standardized team-leader assessment station at the end of each course. Scoring: 0 = Not performed/incorrect, 1 = Partially/performed with prompting, 2 = Performed correctly and independently.
48 and 24 hours from standard amd recertification course respectively
Knowledge retention assessment
Time Frame: 3 months post course
post-course MCQ to evaluate decay; similar to pre-course MCQ
3 months post course

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant satisfaction e
Time Frame: 48hours and 24 from standard and recertification course respectively
scores about course structure, teaching quality, and learning materials; 1: Strongly disagree- 2:disagree- 3: moderate 4: agree- 5: Strongly agree
48hours and 24 from standard and recertification course respectively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Hepatology & Tropical Medicine Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

December 9, 2025

First Submitted That Met QC Criteria

January 15, 2026

First Posted (Actual)

January 22, 2026

Study Record Updates

Last Update Posted (Actual)

January 22, 2026

Last Update Submitted That Met QC Criteria

January 15, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • NHTMRI-IRB-30-2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The individual participant data (IPD) generated in this study will not be made publicly available in order to protect participant confidentiality and comply with ethical regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knowledge

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe